◆英語タイトル:Neurosurgery Devices Market Research Report by Product, Function, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

◆レポート形式:英語 / PDF
Single UserUSD4,949 ⇒換算¥722,554見積依頼/購入/質問フォーム
Enterprise LicenseUSD9,949 ⇒換算¥1,452,554見積依頼/購入/質問フォーム

360iResearch社の調査レポートでは、世界の脳神経外科装置市場規模が2021年の9,198.36百万ドルから、2022年に10,352.76百万ドルまで達すると予測しています。また今後、年平均12.73%成長し、2027年には18,884.49百万ドルまで拡大する見通しです。本調査レポートでは、脳神経外科装置の世界市場を調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別(神経内視鏡装置、神経調節装置)分析、機能別(接近、吸引、デリバリー、診断、その他)分析、用途別(脳深部刺激、神経内視鏡検査、脊髄刺激)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの項目を掲載しています。こちらの調査レポートではAbbott Laboratories Inc.、Ackermann Instrumente GmbH、Adeor Medical AG、B. Braun Melsungen AG、Boston Scientific Corporation、Cordis、Evonos GmbH & Co. KG、Integra LifeSciences Holdings Corporation、Johnson & Johnson Services, Inc.などの企業情報が含まれています。
- 神経内視鏡装置の市場規模
- 神経調節装置の市場規模
- 脳神経外科接近装置の市場規模
- 脳神経外科吸引装置の市場規模
- 脳神経外科デリバリー装置の市場規模
- 脳神経外科診断装置の市場規模
- その他脳神経外科装置の市場規模
- 脳深部刺激における市場規模
- 神経内視鏡検査における市場規模
- 脊髄刺激における市場規模
- 南北アメリカの脳神経外科装置市場規模
- アジア太平洋の脳神経外科装置市場規模
- ヨーロッパ/中東/アフリカの脳神経外科装置市場規模
- その他地域の脳神経外科装置市場規模
❖ レポートの概要 ❖

The Global Neurosurgery Devices Market size was estimated at USD 9,198.36 million in 2021 and expected to reach USD 10,352.76 million in 2022, and is projected to grow at a CAGR 12.73% to reach USD 18,884.49 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Neurosurgery Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Neuroendoscopy Devices and Neuromodulation Devices. The Neuromodulation Devices is further studied across External Neuromodulation Devices and Internal Neuromodulation Devices. The Internal Neuromodulation Devices is further studied across Deep Brain Stimulation Devices and Spinal Cord Stimulation Devices.

Based on Function, the market was studied across Access, Aspirating, Delivery, Diagnostic, Dilatation, Occlusion, and Support.

Based on Application, the market was studied across Deep Brain Stimulation, Neuroendoscopy, and Spinal Cord Stimulation. The Deep Brain Stimulation is further studied across Depression, Parkinson’s Disease, and Tremor. The Neuroendoscopy is further studied across Intraventricular Neuroendoscopy, Transcranial Neuroendoscopy, and Transnasal Neuroendoscopy. The Spinal Cord Stimulation is further studied across Chronic Pain, Failed Back Surgery Syndrome, and Ischemia.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Neurosurgery Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurosurgery Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurosurgery Devices Market, including Abbott Laboratories Inc., Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Boston Scientific Corporation, Cordis, Evonos GmbH & Co. KG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Machida Endoscope Co., Ltd., Medtronic PLC, Nihon Kohden Corporation, NuVasive, Inc., Osteonic Co., Ltd., Penumbra, Inc., Shanghai Kindly Medical Instruments Co., Ltd., Spiegelberg GmbH & Co. KG, Stryker Corporation, and Transact International Private Limited.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Neurosurgery Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurosurgery Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurosurgery Devices Market?
4. What is the competitive strategic window for opportunities in the Global Neurosurgery Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Neurosurgery Devices Market?
6. What is the market share of the leading vendors in the Global Neurosurgery Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Neurosurgery Devices Market?

❖ レポートの目次 ❖

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers Increasing Cases of Neurological Disorders Worldwide Accelerating Applications of Neuromodulation Significant Benefits of the Advanced Neurosurgical Devices Compared to Conventional Devices
5.1.2. Restraints Concerns Related to Neurosurgical Device’s High Cost and Recalls
5.1.3. Opportunities Integration of Robotics in Neurosurgery Devices Emerging Technologies for the Development of Neurosurgery Devices
5.1.4. Challenges Insufficient Skilled and Trained Manpower
5.2. Cumulative Impact of COVID-19

6. Neurosurgery Devices Market, by Product
6.1. Introduction
6.2. Neuroendoscopy Devices
6.3. Neuromodulation Devices
6.4.1. External Neuromodulation Devices
6.4.2. Internal Neuromodulation Devices Deep Brain Stimulation Devices Spinal Cord Stimulation Devices

7. Neurosurgery Devices Market, by Function
7.1. Introduction
7.2. Access
7.3. Aspirating
7.4. Delivery
7.5. Diagnostic
7.6. Dilatation
7.7. Occlusion
7.8. Support

8. Neurosurgery Devices Market, by Application
8.1. Introduction
8.2. Deep Brain Stimulation
8.3.1. Depression
8.3.2. Parkinson’s Disease
8.3.3. Tremor
8.3. Neuroendoscopy
8.4.1. Intraventricular Neuroendoscopy
8.4.2. Transcranial Neuroendoscopy
8.4.3. Transnasal Neuroendoscopy
8.4. Spinal Cord Stimulation
8.5.1. Chronic Pain
8.5.2. Failed Back Surgery Syndrome
8.5.3. Ischemia

9. Americas Neurosurgery Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Neurosurgery Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Neurosurgery Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Ackermann Instrumente GmbH
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Adeor Medical AG
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. B. Braun Melsungen AG
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Boston Scientific Corporation
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cordis
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Evonos GmbH & Co. KG
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Integra LifeSciences Holdings Corporation
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Johnson & Johnson Services, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Karl Storz SE & Co. KG
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Machida Endoscope Co., Ltd.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Medtronic PLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Nihon Kohden Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. NuVasive, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Osteonic Co., Ltd.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Penumbra, Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Shanghai Kindly Medical Instruments Co., Ltd.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Spiegelberg GmbH & Co. KG
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Stryker Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Transact International Private Limited
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

❖ 免責事項 ❖

★リサーチレポート[ 脳神経外科装置世界市場予測(~2027年)(Neurosurgery Devices Market Research Report by Product, Function, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19)]についてメールでお問い合わせはこちらでお願いします。